307 related articles for article (PubMed ID: 27397734)
21. Erythrocyte ω-3 polyunsaturated fatty acids are inversely associated with the risk of oral cancer: a case-control study.
Chen Q; Wang J; Wang J; Lin J; Chen L; Lin LS; Pan LZ; Shi B; Qiu Y; Zheng XY; Chen F; He BC; Liu FQ
Nutr Diabetes; 2020 Sep; 10(1):35. PubMed ID: 32989214
[TBL] [Abstract][Full Text] [Related]
22. The association between dietary omega-3 fatty acids and cardiovascular death: the Singapore Chinese Health Study.
Koh AS; Pan A; Wang R; Odegaard AO; Pereira MA; Yuan JM; Koh WP
Eur J Prev Cardiol; 2015 Mar; 22(3):364-72. PubMed ID: 24343844
[TBL] [Abstract][Full Text] [Related]
23. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
Rupp H; Rupp TP; Wagner D; Alter P; Maisch B
Herz; 2006 Dec; 31 Suppl 3():30-49. PubMed ID: 17575804
[TBL] [Abstract][Full Text] [Related]
24. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.
Kuwamura Y; Shoji T; Okute Y; Yamazaki Y; Motoyama K; Morioka T; Mori K; Fukumoto S; Tsujimoto Y; Shioi A; Emoto M; Inaba M
J Ren Nutr; 2018 Jan; 28(1):54-63. PubMed ID: 29089279
[TBL] [Abstract][Full Text] [Related]
25. Changes in Erythrocyte Omega-3 Fatty Acids in German Employees upon Dietary Advice by Corporate Health.
Rein D; Claus M; Frosch W; März W; Lorkowski S; Webendoerfer S; Schreiner T
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113826
[TBL] [Abstract][Full Text] [Related]
26. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
27. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
28. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
29. Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort.
Pertiwi K; Küpers LK; de Goede J; Zock PL; Kromhout D; Geleijnse JM
J Am Heart Assoc; 2021 Dec; 10(23):e022617. PubMed ID: 34845924
[TBL] [Abstract][Full Text] [Related]
30. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
31. Associations Between Whole Blood and Dietary Omega-3 Polyunsaturated Fatty Acid Levels in Collegiate Athletes.
Wilson PB; Madrigal LA
Int J Sport Nutr Exerc Metab; 2016 Dec; 26(6):497-505. PubMed ID: 27098595
[TBL] [Abstract][Full Text] [Related]
32. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
33. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
34. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
35. Low long chain omega-3 fatty acid status in middle-aged women.
Gellert S; Schuchardt JP; Hahn A
Prostaglandins Leukot Essent Fatty Acids; 2017 Feb; 117():54-59. PubMed ID: 28237088
[TBL] [Abstract][Full Text] [Related]
36. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement.
Sarter B; Kelsey KS; Schwartz TA; Harris WS
Clin Nutr; 2015 Apr; 34(2):212-8. PubMed ID: 24679552
[TBL] [Abstract][Full Text] [Related]
37. n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.
Erkkilä AT; Lehto S; Pyörälä K; Uusitupa MI
Am J Clin Nutr; 2003 Jul; 78(1):65-71. PubMed ID: 12816772
[TBL] [Abstract][Full Text] [Related]
38. Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.
Nagahara Y; Motoyama S; Sarai M; Ito H; Kawai H; Takakuwa Y; Miyagi M; Shibata D; Takahashi H; Naruse H; Ishii J; Ozaki Y
Atherosclerosis; 2016 Jul; 250():30-7. PubMed ID: 27175609
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
40. Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients.
Harris WS; Pottala JV; Varvel SA; Borowski JJ; Ward JN; McConnell JP
Prostaglandins Leukot Essent Fatty Acids; 2013 Apr; 88(4):257-63. PubMed ID: 23375840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
